Syntax Research’s Sanofi SNY Stock Holding History

Syntax Research’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-200	Closed	-$9.95K	–	180
2023 Q4	$9.95K	Buy	+200	New	+$9.78K	0.01%	136

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Syntax Research's SNY Position: Q1 2024 in Review

Syntax Research sold out of Sanofi (SNY) in Q1 2024, closing a stake of 200 shares — an estimated $9.95K sold.

Syntax Research first reported a position in SNY in Q4 2023 and held it in 1 quarter. The position peaked at $9.95K in Q4 2023. 711 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

Syntax Research reported no remaining Sanofi position as of Q1 2024 after selling out during the quarter.
Syntax Research sold 200 Sanofi shares in Q1 2024, an estimated $9.95K.
Syntax Research first reported a position in Sanofi in Q4 2023 and held it in 1 quarter.
Syntax Research's Sanofi position peaked at $9.95K in Q4 2023.
711 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on Syntax Research's 13F filing for Q1 2024, filed 7 May 2024.